Biomedical Advanced Research and Development Authority
COVID-19 Vaccines: Moderna declares successful trial results after Pfizer
The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials
- Al-Qassam video depicts rescue of Israeli captives from IOF bombing in Gaza
- Eight wounded as Syrian-Lebanese border tension comes back to the fore
- Trump’s mass deportation operation escalates with workplace raids
- Jordan bans Muslim Brotherhood, confiscates its assets after alleged security plot
- Medics on hunger strike against Gaza genocide reach European Parliament
